254 related articles for article (PubMed ID: 16863439)
21. Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2).
Chu XY; Strauss JR; Mariano MA; Li J; Newton DJ; Cai X; Wang RW; Yabut J; Hartley DP; Evans DC; Evers R
J Pharmacol Exp Ther; 2006 May; 317(2):579-89. PubMed ID: 16421286
[TBL] [Abstract][Full Text] [Related]
22. Dubin-Johnson-like black liver with normal bilirubin level.
Kobayashi Y; Ishihara T; Wada M; Kajihara S; Araki J; Mifuji R; Itani T; Kuroda M; Urawa F; Kaito M; Adachi Y
J Gastroenterol; 2004 Sep; 39(9):892-5. PubMed ID: 15565410
[TBL] [Abstract][Full Text] [Related]
23. Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome.
Hashimoto K; Uchiumi T; Konno T; Ebihara T; Nakamura T; Wada M; Sakisaka S; Maniwa F; Amachi T; Ueda K; Kuwano M
Hepatology; 2002 Nov; 36(5):1236-45. PubMed ID: 12395335
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.
Keppler D
Handb Exp Pharmacol; 2011; (201):299-323. PubMed ID: 21103974
[TBL] [Abstract][Full Text] [Related]
25. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver.
Shoda J; Miura T; Utsunomiya H; Oda K; Yamamoto M; Kano M; Ikegami T; Tanaka N; Akita H; Ito K; Suzuki H; Sugiyama Y
Hepatology; 2004 Jan; 39(1):167-78. PubMed ID: 14752835
[TBL] [Abstract][Full Text] [Related]
26. Physiological, pharmacological and clinical features of the multidrug resistance protein 2.
Fardel O; Jigorel E; Le Vee M; Payen L
Biomed Pharmacother; 2005 Apr; 59(3):104-14. PubMed ID: 15795103
[TBL] [Abstract][Full Text] [Related]
27. Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites.
Slot AJ; Wise DD; Deeley RG; Monks TJ; Cole SP
Drug Metab Dispos; 2008 Mar; 36(3):552-60. PubMed ID: 18079363
[TBL] [Abstract][Full Text] [Related]
28. Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome.
Mor-Cohen R; Zivelin A; Rosenberg N; Shani M; Muallem S; Seligsohn U
J Biol Chem; 2001 Oct; 276(40):36923-30. PubMed ID: 11477083
[TBL] [Abstract][Full Text] [Related]
29. Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2).
Zimmermann C; van de Wetering K; van de Steeg E; Wagenaar E; Vens C; Schinkel AH
Drug Metab Dispos; 2008 Apr; 36(4):631-40. PubMed ID: 18180270
[TBL] [Abstract][Full Text] [Related]
30. A recurrent ABCC2 p.G693R mutation resulting in loss of function of MRP2 and hyperbilirubinemia in Dubin-Johnson syndrome in China.
Wu L; Li Y; Song Y; Zhou D; Jia S; Xu A; Zhang W; You H; Jia J; Huang J; Ou X
Orphanet J Rare Dis; 2020 Mar; 15(1):74. PubMed ID: 32183854
[TBL] [Abstract][Full Text] [Related]
31. Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.
Hirouchi M; Suzuki H; Sugiyama Y
Pharm Res; 2005 Apr; 22(4):661-6. PubMed ID: 15846474
[TBL] [Abstract][Full Text] [Related]
32. Expression of the multidrug transporter MRP2 in the blood-brain barrier after pilocarpine-induced seizures in rats.
Hoffmann K; Gastens AM; Volk HA; Löscher W
Epilepsy Res; 2006 Apr; 69(1):1-14. PubMed ID: 16504477
[TBL] [Abstract][Full Text] [Related]
33. Homozygous mutation Arg768Trp in the ABC-transporter encoding gene MRP2/cMOAT/ABCC2 causes Dubin-Johnson syndrome in a Caucasian patient.
Materna V; Lage H
J Hum Genet; 2003; 48(9):484-486. PubMed ID: 12942343
[TBL] [Abstract][Full Text] [Related]
34. Clinical, Pathologic, and Genetic Features of Neonatal Dubin-Johnson Syndrome: A Multicenter Study in Japan.
Togawa T; Mizuochi T; Sugiura T; Kusano H; Tanikawa K; Sasaki T; Ichinose F; Kagimoto S; Tainaka T; Uchida H; Saitoh S
J Pediatr; 2018 May; 196():161-167.e1. PubMed ID: 29499989
[TBL] [Abstract][Full Text] [Related]
35. Generation and characterization of a novel multidrug resistance protein 2 humanized mouse line.
Scheer N; Balimane P; Hayward MD; Buechel S; Kauselmann G; Wolf CR
Drug Metab Dispos; 2012 Nov; 40(11):2212-8. PubMed ID: 22917771
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships for interaction with multidrug resistance protein 2 (ABCC2/MRP2): the role of torsion angle for a series of biphenyl-substituted heterocycles.
Lai Y; Xing L; Poda GI; Hu Y
Drug Metab Dispos; 2007 Jun; 35(6):937-45. PubMed ID: 17371800
[TBL] [Abstract][Full Text] [Related]
37. A family of drug transporters: the multidrug resistance-associated proteins.
Borst P; Evers R; Kool M; Wijnholds J
J Natl Cancer Inst; 2000 Aug; 92(16):1295-302. PubMed ID: 10944550
[TBL] [Abstract][Full Text] [Related]
38. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice.
Tanaka Y; Kobayashi Y; Gabazza EC; Higuchi K; Kamisako T; Kuroda M; Takeuchi K; Iwasa M; Kaito M; Adachi Y
Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G656-62. PubMed ID: 11897625
[TBL] [Abstract][Full Text] [Related]
39. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
Smeets PH; van Aubel RA; Wouterse AC; van den Heuvel JJ; Russel FG
J Am Soc Nephrol; 2004 Nov; 15(11):2828-35. PubMed ID: 15504935
[TBL] [Abstract][Full Text] [Related]
40. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2.
Keppler D; Leier I; Jedlitschky G
Biol Chem; 1997 Aug; 378(8):787-91. PubMed ID: 9377473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
